Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of BI 425809 in schizophrenia
jRCT2080223908Phase 2Completed
- Start
- May 2018
- Modality
- Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of iclepertin in schizophrenia (5 arms). Started May 2018; status: completed.
02
Drugs
iclepertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080223908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223908.